|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.96 USD | +1.61% |
|
+2.18% | +28.76% |
| 06-05 | Target Recalls Baby Wipes Over Bacterial Contamination | MT |
| 06-05 | Target Recalls Up & Up Fragrance Free and Fresh Cucumber Scented Baby Wipes Due to Potential Microbial Contamination | CI |
| Fiscal Period: January | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 10.78 | 4.62 | 6.79 | 6.34 | 5.26 | |||||
Return on Total Capital | 19.25 | 8.29 | 11.6 | 10.61 | 8.69 | |||||
Return On Equity % | 50.95 | 23.11 | 33.55 | 29.12 | 24.03 | |||||
Return on Common Equity | 50.95 | 23.11 | 33.55 | 29.12 | 24.03 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 29.28 | 24.64 | 27.63 | 28.21 | 27.93 | |||||
SG&A Margin | 18.52 | 18.83 | 19.89 | 20.45 | 20.72 | |||||
EBITDA Margin % | 11.04 | 6.1 | 8.1 | 8.18 | 7.7 | |||||
EBITA Margin % | 8.55 | 3.63 | 5.49 | 5.39 | 4.71 | |||||
EBIT Margin % | 8.55 | 3.63 | 5.49 | 5.39 | 4.71 | |||||
Income From Continuing Operations Margin % | 6.55 | 2.55 | 3.85 | 3.84 | 3.54 | |||||
Net Income Margin % | 6.55 | 2.55 | 3.85 | 3.84 | 3.54 | |||||
Net Avail. For Common Margin % | 6.55 | 2.55 | 3.85 | 3.84 | 3.54 | |||||
Normalized Net Income Margin | 5.11 | 2 | 3.14 | 3.13 | 2.68 | |||||
Levered Free Cash Flow Margin | 3.67 | -2.43 | 2.17 | 3.45 | 2.47 | |||||
Unlevered Free Cash Flow Margin | 3.92 | -2.15 | 2.46 | 3.69 | 2.74 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.02 | 2.04 | 1.98 | 1.88 | 1.79 | |||||
Fixed Assets Turnover | 3.54 | 3.36 | 3.04 | 2.91 | 2.82 | |||||
Receivables Turnover (Average Receivables) | 142.72 | 107.37 | 102.72 | 112.83 | 92.6 | |||||
Inventory Turnover (Average Inventory) | 6.11 | 6 | 6.12 | 6.21 | 6.03 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.99 | 0.92 | 0.91 | 0.94 | 0.94 | |||||
Quick Ratio | 0.33 | 0.2 | 0.27 | 0.3 | 0.34 | |||||
Operating Cash Flow to Current Liabilities | 0.4 | 0.21 | 0.45 | 0.35 | 0.31 | |||||
Days Sales Outstanding (Average Receivables) | 2.55 | 3.39 | 3.61 | 3.23 | 3.93 | |||||
Days Outstanding Inventory (Average Inventory) | 59.62 | 60.65 | 60.58 | 58.59 | 60.36 | |||||
Average Days Payable Outstanding | 65.94 | 64.42 | 62.35 | 59.17 | 62.24 | |||||
Cash Conversion Cycle (Average Days) | -3.77 | -0.39 | 1.84 | 2.64 | 2.05 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 128.38 | 170.53 | 147.18 | 135.52 | 125.52 | |||||
Total Debt / Total Capital | 56.21 | 63.04 | 59.54 | 57.54 | 55.66 | |||||
LT Debt/Equity | 125.06 | 166.74 | 136.42 | 121.96 | 110.04 | |||||
Long-Term Debt / Total Capital | 54.76 | 61.63 | 55.19 | 51.78 | 48.79 | |||||
Total Liabilities / Total Assets | 76.16 | 78.94 | 75.74 | 74.61 | 72.83 | |||||
EBIT / Interest Expense | 21.52 | 8.28 | 11.75 | 13.96 | 11.1 | |||||
EBITDA / Interest Expense | 28.68 | 14.87 | 18.39 | 22.74 | 19.64 | |||||
(EBITDA - Capex) / Interest Expense | 20.26 | 3.31 | 8.81 | 15.71 | 11.26 | |||||
Total Debt / EBITDA | 1.36 | 2.69 | 2.14 | 2.13 | 2.32 | |||||
Net Debt / EBITDA | 0.87 | 2.38 | 1.73 | 1.62 | 1.69 | |||||
Total Debt / (EBITDA - Capex) | 1.93 | 12.12 | 4.47 | 3.08 | 4.05 | |||||
Net Debt / (EBITDA - Capex) | 1.24 | 10.71 | 3.61 | 2.34 | 2.95 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 13.3 | 2.94 | -1.57 | -0.79 | -1.68 | |||||
Gross Profit, 1 Yr. Growth % | 12.43 | -13.37 | 10.36 | 1.62 | -2.64 | |||||
EBITDA, 1 Yr. Growth % | 25.59 | -43.1 | 30.65 | 0.22 | -7.43 | |||||
EBITA, 1 Yr. Growth % | 32.6 | -56.3 | 48.99 | -2.73 | -13.96 | |||||
EBIT, 1 Yr. Growth % | 32.6 | -56.3 | 48.99 | -2.73 | -13.96 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 59.02 | -59.98 | 48.85 | -1.14 | -9.44 | |||||
Net Income, 1 Yr. Growth % | 59.02 | -59.98 | 48.85 | -1.14 | -9.44 | |||||
Normalized Net Income, 1 Yr. Growth % | 36.45 | -59.76 | 54.97 | -1.3 | -15.69 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 63.19 | -57.59 | 49.5 | -0.89 | -8.24 | |||||
Accounts Receivable, 1 Yr. Growth % | 32.33 | 40 | -23.78 | 12.01 | 26.75 | |||||
Inventory, 1 Yr. Growth % | 30.5 | -2.9 | -11.95 | 7.18 | -3.42 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.6 | 11.17 | 6.7 | 0.9 | 1.81 | |||||
Total Assets, 1 Yr. Growth % | 5 | -0.88 | 3.79 | 4.36 | 2.98 | |||||
Tangible Book Value, 1 Yr. Growth % | -11.63 | -13.01 | 20.84 | 9.64 | 10.68 | |||||
Common Equity, 1 Yr. Growth % | -11.17 | -12.43 | 19.59 | 9.19 | 10.22 | |||||
Cash From Operations, 1 Yr. Growth % | -18.05 | -53.41 | 114.56 | -14.55 | -10.93 | |||||
Capital Expenditures, 1 Yr. Growth % | 33.79 | 55.98 | -13.06 | -39.85 | 28.92 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -42.06 | -168.09 | -188.1 | 57.71 | -29.65 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -40.71 | -156.58 | -212.66 | 48.72 | -27.18 | |||||
Dividend Per Share, 1 Yr. Growth % | 17.91 | 25.32 | 10.1 | 1.83 | 1.8 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 16.49 | 8 | 0.66 | -1.18 | -1.23 | |||||
Gross Profit, 2 Yr. CAGR % | 15.55 | -0.9 | -2.22 | 5.89 | -0.53 | |||||
EBITDA, 2 Yr. CAGR % | 26.34 | -14.42 | -13.78 | 14.42 | -3.68 | |||||
EBITA, 2 Yr. CAGR % | 38.44 | -22.59 | -19.31 | 20.38 | -8.52 | |||||
EBIT, 2 Yr. CAGR % | 38.44 | -22.59 | -19.31 | 20.38 | -8.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 45.77 | -20.22 | -22.82 | 21.31 | -5.38 | |||||
Net Income, 2 Yr. CAGR % | 45.5 | -20.22 | -22.82 | 21.31 | -5.38 | |||||
Normalized Net Income, 2 Yr. CAGR % | 43.19 | -24.55 | -21.04 | 23.68 | -8.78 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 49.13 | -16.81 | -20.37 | 21.72 | -4.64 | |||||
Accounts Receivable, 2 Yr. CAGR % | 29.49 | 36.11 | 3.3 | -7.6 | 19.15 | |||||
Inventory, 2 Yr. CAGR % | 24.34 | 12.57 | -7.53 | -2.85 | 1.74 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.82 | 8.35 | 8.91 | 3.76 | 1.35 | |||||
Total Assets, 2 Yr. CAGR % | 12.16 | 2.02 | 1.43 | 4.07 | 3.67 | |||||
Tangible Book Value, 2 Yr. CAGR % | 4.49 | -12.32 | 2.52 | 15.14 | 10.16 | |||||
Common Equity, 2 Yr. CAGR % | 4.12 | -11.8 | 2.33 | 14.27 | 9.7 | |||||
Cash From Operations, 2 Yr. CAGR % | 10.09 | -38.21 | -0.02 | 35.41 | -12.76 | |||||
Capital Expenditures, 2 Yr. CAGR % | 8.2 | 44.46 | 16.45 | -27.68 | -11.94 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 6.91 | -36.52 | -22.55 | 17.88 | 5.28 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 6.02 | -41.49 | -20.16 | 29.44 | 4.03 | |||||
Dividend Per Share, 2 Yr. CAGR % | 10.24 | 21.56 | 17.46 | 5.89 | 1.82 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 12.05 | 11.79 | 4.71 | 0.18 | -1.34 | |||||
Gross Profit, 3 Yr. CAGR % | 12.06 | 4.97 | 2.72 | -1.06 | 2.96 | |||||
EBITDA, 3 Yr. CAGR % | 20.43 | -3.15 | -1.46 | -9.34 | 6.62 | |||||
EBITA, 3 Yr. CAGR % | 28.8 | -5.74 | -3.71 | -14.12 | 7.63 | |||||
EBIT, 3 Yr. CAGR % | 28.94 | -5.74 | -3.71 | -14.12 | 7.63 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 33.34 | -5.26 | -1.79 | -16.18 | 10.05 | |||||
Net Income, 3 Yr. CAGR % | 33.23 | -5.37 | -1.79 | -16.18 | 10.05 | |||||
Normalized Net Income, 3 Yr. CAGR % | 31.96 | -6.21 | -4.09 | -14.94 | 8.85 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 36.86 | -1.93 | 1.14 | -14.35 | 10.78 | |||||
Accounts Receivable, 3 Yr. CAGR % | - | 32.9 | 12.19 | 6.12 | 2.67 | |||||
Inventory, 3 Yr. CAGR % | 13.54 | 14.5 | 3.72 | -2.87 | -3.04 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 3.78 | 6.21 | 7.8 | 6.17 | 3.11 | |||||
Total Assets, 3 Yr. CAGR % | 9.23 | 7.63 | 2.6 | 2.39 | 3.71 | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.72 | -1.7 | -2.43 | 4.86 | 13.63 | |||||
Common Equity, 3 Yr. CAGR % | 4.32 | -1.72 | -2.38 | 4.57 | 12.9 | |||||
Cash From Operations, 3 Yr. CAGR % | 13.03 | -17.35 | -6.44 | -5.12 | 17.76 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.26 | 22.23 | 21.96 | -6.56 | -12.31 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 35.89 | -8.02 | -29.19 | -1.83 | -0.73 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 31.21 | -14.01 | -27.21 | -1.76 | 6.88 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.84 | 15.06 | 17.61 | 12 | 4.51 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.57 | 8.46 | 7.35 | 6.41 | 2.29 | |||||
Gross Profit, 5 Yr. CAGR % | 8 | 4.49 | 6.11 | 5.28 | 1.34 | |||||
EBITDA, 5 Yr. CAGR % | 9.86 | -0.56 | 5.36 | 3.53 | -2.35 | |||||
EBITA, 5 Yr. CAGR % | 12.59 | -2.03 | 6.83 | 3.95 | -5.66 | |||||
EBIT, 5 Yr. CAGR % | 12.65 | -1.97 | 6.9 | 3.95 | -5.66 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 21.11 | -0.9 | 7.15 | 4.59 | -3.24 | |||||
Net Income, 5 Yr. CAGR % | 20.5 | -0.94 | 7.1 | 4.51 | -3.24 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.36 | -1.95 | 7.46 | 4.76 | -5.99 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 25.22 | 2.48 | 10.2 | 6.92 | -1.21 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | 14.92 | 14.92 | |||||
Inventory, 5 Yr. CAGR % | 10.84 | 9.44 | 4.59 | 7.22 | 2.92 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.51 | 5.28 | 5.8 | 5.22 | 5.17 | |||||
Total Assets, 5 Yr. CAGR % | 7.53 | 5.76 | 6.04 | 6.19 | 3.03 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.48 | -0.66 | 3.84 | 4.72 | 2.44 | |||||
Common Equity, 5 Yr. CAGR % | 3.21 | -0.73 | 3.52 | 4.39 | 2.28 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.64 | -10.34 | 7.62 | 0.69 | -9.02 | |||||
Capital Expenditures, 5 Yr. CAGR % | 18.03 | 16.89 | 6.45 | -0.92 | 7.07 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 2.43 | -6.35 | 8.52 | 1.58 | -16.99 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 1.76 | -10.13 | 7.56 | 1.28 | -16.01 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.38 | 10.17 | 11.59 | 11.3 | 11.02 |
- Stock Market
- Stocks
- TGT Stock
- Financials Target Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















